Popular Articles

Medicare Analysis Finds Too Many Needless Deaths At Hospitals
A new Medicare analysis by the Centers for Medicare and Medicaid Services found a "double failure" at U.S. hospitals. Its release comes as the White House and Congress seek ways to reward quality over quantity of care in health care reform. USA Today reports that "Too many people die needlessly at U.S. hospitals, according to a sweeping new Medicare analysis showing wide variation in death rates between the best hospitals and the worst. The analysis examined death rates for heart attacks, heart failure and pneumonia at more than 4,600 hospitals across the USA. At 5.9% of hospitals, patients with pneumonia died at rates significantly higher than the national average. With heart failure, 3.4% of hospitals had death rates higher than the average, and 1.2% of hospitals were higher when it came to heart attack. Researchers also found that the majority of U.S. hospitals operate the equivalent of revolving doors for their patients. One of every four heart failure patients and slightly less than one in five heart attack and pneumonia patients land back in the hospital within 30 days, data show."

Common Cancer Drug May Increase Risk Of Deadly GI Perforations
Cancer patients treated with the widely used drug bevacizumab (Avastin) in combination with chemotherapy are at greater risk of life-thereatening gastrointestinal (GI) perforations. This is the conclusion of Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center, in a study published online and in the June print issue of The Lancet Oncology.
News of the day
Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients
Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the postprandial glycemic excursions following a standardized test meal after treatment with either insulin lispro+PH20 or regular insulin+PH20 relative to treatment with lispro (Humalog) alone.
Nutrition

All Party Parliamentary Group For Parkinson's Disease Announces Report & Parkinson's Disease Society Launches Fair Care For Parkinson's

When: 8 July 2009 6:00pm - 8:00pm What: Launch of the APPG"s report into inequalities of access to services for people with Parkinson"s and their carers. In response to the report, the Parkinson"s Disease Society will also launch Fair Care for Parkinson"s, calling for the Government to ensure the APPG report recommendations are carried out. Where: Macmillan Room, Portcullis House, Westminster An inquiry by the All Party Parliamentary Group (APPG) for Parkinson"s has highlighted severe inequalities in access to Parkinson"s services, despite the clear standards and evidence base set out in the National Service Framework for long term neurological conditions, and the NICE Parkinson"s disease guideline. Nearly 400 individuals and organisations including national and local health and social care providers, regulators, professional bodies and charities, provided written and oral evidence to the inquiry. The disturbing findings from this report will be announced on 8 July 2009. The PDS is launching Fair Care for Parkinson"s to ensure all people affected by Parkinson"s have equal access to the services they need. Guest speakers will include: - Baroness Gale, Chair, APPG for Parkinson"s Disease - Ann Keen MP, Parliamentary Under Secretary for Health Services - Steve Ford, Chief Executive of the Parkinson"s Disease Society - A speaker sharing their experiences of living with Parkinson"s About the APPG for Parkinson"s Disease Chair of the APPG for Parkinson"s Disease: - Baroness Gale Officers of the APPG for Parkinson"s disease: - Baroness Finlay of Llandaff - Vice-Chair - Mark Hunter MP - Vice-Chair - Anne Milton MP - Vice-Chair - Jeremy Browne MP - Treasurer - Lord Brooke of Sutton Mandeville - Secretary - Paul Burstow MP - Secretary - Madeleine Moon MP - Secretary - The APPG for Parkinson"s Disease was established in June 2008 in order to keep Parkinson"s disease and relevant public policy issues on the political agenda - The Parkinson"s Disease Society (PDS) acts as Secretariat for the APPG for Parkinson"s disease - The PDS member"s survey 2007 Life with Parkinson"s today - room for improvement identified that access to public services such as the NHS, social services and transport in England for people with Parkinson"s and their carers varies considerably About Parkinson"s Disease - Approximately 120,000 people in the UK have Parkinson"s - 10,000 people are diagnosed in the UK every year, and one in 20 is under 40 - Parkinson"s is a progressive neurological condition caused by the loss of dopamine in the brain, for which there is currently no cure. Whilst it is not life threatening, Parkinson"s seriously affects day to day activities that we take for granted like walking, writing, speaking -- Key symptoms are: - Tremor 1 Rigid muscles 2 Slowness of movement Parkinson"s Disease Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):